IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy. 2006

Louisa K Wilcock, and James N Francis, and Stephen R Durham
Upper Respiratory Medicine, Imperial College, National Heart and Lung Institute, Dovehouse Street, London SW3 6LY, UK.

IgE-facilitated allergen presentation (FAP) is an important pathogenic mechanism in allergic disease and represents a potential therapeutic target. Allergen immunotherapy is a highly effective therapy, particularly in patients with seasonal pollinosis who fail to respond to usual pharmacotherapy. Allergen immunotherapy induces "blocking" IgG antibodies that are detectable in serum and have been shown to inhibit IgE-FAP in vitro. This review summarizes the main components involved in IgE-FAP and the potential value of a validated functional assay of serum inhibitory antibodies for IgE-FAP for monitoring the clinical response to immunotherapy.

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen
D017951 Antigen Presentation The process by which antigen is presented to lymphocytes in a form they can recognize. This is performed by antigen presenting cells (APCs). Some antigens require processing before they can be recognized. Antigen processing consists of ingestion and partial digestion of the antigen by the APC, followed by presentation of fragments on the cell surface. (From Rosen et al., Dictionary of Immunology, 1989) Antigen Processing,Antigen Presentations,Antigen Processings

Related Publications

Louisa K Wilcock, and James N Francis, and Stephen R Durham
April 1993, Journal of immunology (Baltimore, Md. : 1950),
Louisa K Wilcock, and James N Francis, and Stephen R Durham
October 2010, Allergy,
Louisa K Wilcock, and James N Francis, and Stephen R Durham
September 2021, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
Louisa K Wilcock, and James N Francis, and Stephen R Durham
August 2016, Journal of controlled release : official journal of the Controlled Release Society,
Louisa K Wilcock, and James N Francis, and Stephen R Durham
January 2014, European annals of allergy and clinical immunology,
Louisa K Wilcock, and James N Francis, and Stephen R Durham
April 2018, Allergy,
Louisa K Wilcock, and James N Francis, and Stephen R Durham
February 1995, Clinical and experimental immunology,
Louisa K Wilcock, and James N Francis, and Stephen R Durham
January 1997, Advances in experimental medicine and biology,
Louisa K Wilcock, and James N Francis, and Stephen R Durham
August 1995, Immunology today,
Louisa K Wilcock, and James N Francis, and Stephen R Durham
January 2024, Medicina (Kaunas, Lithuania),
Copied contents to your clipboard!